ReviewDer Anaesthesist2009
[Perioperative management of patients with coronary stents in non-cardiac surgery].
Review in Der Anaesthesist, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Guideline
- Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding.The Cochrane database of systematic reviews · 2016Pooled it
- [Preoperative evaluation of adult patients prior to elective, non-cardiac surgery. Joint recommendations of German Society of Anesthesiology and Intensive Care Medicine, German Society of Surgery and German Society of Internal Medicine].Der Urologe. Ausg. A · 2011Guideline
- Guideline
- Trial
- Review
- Review
- [Risk consideration for peridural catheter removal in acute coronary syndrome. Epidural hematoma versus stent thrombosis].Der Anaesthesist · 2014Article
- The perioperative management of treatment with anticoagulants and platelet aggregation inhibitors.Deutsches Arzteblatt international · 2013Review
- [On preoperative risk evaluation of adult patients before elective non-cardiac surgery: results of a survey on clinical practice in the Federal State of Hessen].Der Anaesthesist · 2013Article
- [Dual antiplatelet therapy and operative medicine : open questions despite guidelines?].Der Anaesthesist · 2012Article
- [Platelet function: new drugs, new assays : possible impacts on operative medicine?].Der Anaesthesist · 2012Review
- [Panta rhei : blood, professional career and anesthesiological self-conception].Der Anaesthesist · 2012Article
- [Antiplatelet therapy after coronary stenting and its importance in total joint arthroplasty].Der Orthopade · 2012Review
- Standard perioperative management in gastrointestinal surgery.Langenbeck's archives of surgery · 2011Review
- [Current aspects of anesthetic management in urological patients].Der Urologe. Ausg. A · 2010Review
- Review
- [Perioperative management of patients with coronary stents in non-cardiac surgery].Der Anaesthesist · 2010Article
- [Perioperative management of patients with coronary stents undergoing non-cardiac surgery. Better to accept loss of blood than a cardiac infarct?].Der Anaesthesist · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In patients with coronary stents scheduled for surgery the question arises whether and how antiplatelet therapy should be continued. Risks of perioperative bleeding and of acute stent thrombosis have to be considered simultaneously. The bleeding risk depends primarily on the kind of surgery and on patient comorbidity. The risk of stent thrombosis is increased in these patients due to the thrombogenic surface of the stents. The main determinants are hereby the time duration after stent implantation, the kind of the stent [uncoated (bare-metal stent, BMS) or coated (drug-eluting stent, DES)], as well as angiographic and clinical patient factors. Therefore, perioperative antiplatelet therapy has to be individually adapted for each patient. Bridging with heparin is ineffective. Bridging with intravenous antiplatelet drugs during the perioperative interruption of oral antiplatelet therapy might be a potential procedure in high-risk patients. Whether bedside monitoring of antiplatelet therapy improves the perioperative management of these patients and reduces adverse outcome is object of current studies.
Indexed as
Identifiers
19823781What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.